Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.819)

41

Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren : a randomised controlled trial (ViDiKids)

enthalten in: BMJ paediatrics open | 2024

von Middelkoop, K. | Micklesfield, L. | Stewart, J. | +13

42

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age : Results of a randomized phase 3 study

enthalten in: Vaccine | 2024

von Baker, J. | Aliabadi, N. | Munjal, I. | +8

43

Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants : A single blind, randomized, active-controlled, Phase-III study

enthalten in: Vaccine | 2024

von Matur, R. | Thuluva, S. | Gunneri, S. | +9

44

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS) : a randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Giamarellos-Bourboulis, E. | Siampanos, A. | Bolanou, A. | +29

ErratumIn: Lancet Respir Med. 2024 Feb 21;:. - PMID 38401557

45

SABR-Dual : a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

enthalten in: BMC cancer | 2024

von Fredman, E. | Icht, O. | Moore, A. | +4

46

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

47

Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE) : a randomized, open-label, phase 3 trial

enthalten in: Journal of hematology & oncology | 2024

von Wang, X. | Lu, C. | Wei, B. | +23

48

Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI) : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2024

von Kankasa, C. | Mennecier, A. | Sakana, B. | +15

49

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES) : a randomised, parallel, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Steel, J. | George, C. | Terhorst, L. | +19

50

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18) : a randomised, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2024

von Lorusso, D. | Xiang, Y. | Hasegawa, K. | +32